OPTINOSE INC. - COMMON STOCK
1.0100
03-May-24 15:59:57
15 minutes delayed
Stocks
+0.1324
+15.09%
Today's range
0.8799 - 1.0100
ISIN
N/A
Source
NASDAQ
-
Optinose Reports First Quarter 2022 Financial Results and Operational Updates
12 May 2022 07:00:19 By Nasdaq GlobeNewswire
-
Optinose Announces Reporting Date for First Quarter 2022 Financial Results
05 May 2022 17:00:00 By Nasdaq GlobeNewswire
-
Optinose Announces Appointment of R. John Fletcher to the Board
26 Apr 2022 08:00:03 By Nasdaq GlobeNewswire
-
Optinose to Present at the Needham Virtual Healthcare Conference
08 Apr 2022 08:30:00 By Nasdaq GlobeNewswire
-
08 Mar 2022 07:00:01 By Nasdaq GlobeNewswire
-
07 Mar 2022 07:00:01 By Nasdaq GlobeNewswire
-
Optinose Announces Reporting Date for Fourth Quarter 2021 Financial Results
04 Mar 2022 14:00:00 By Nasdaq GlobeNewswire
-
Optinose Announces Appointment of Two New Members to Board of Directors
13 Dec 2021 07:54:10 By Nasdaq GlobeNewswire
-
Optinose to Present at the Piper Sandler Virtual Healthcare Conference
23 Nov 2021 07:00:00 By Nasdaq GlobeNewswire
-
Optinose Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
18 Nov 2021 16:30:00 By Nasdaq GlobeNewswire
-
Optinose Announces Closing of $46.0 Million Public Offering of Common Stock
18 Nov 2021 14:00:00 By Nasdaq GlobeNewswire
-
Optinose Announces Pricing of Public Offering of Common Stock
16 Nov 2021 08:01:59 By Nasdaq GlobeNewswire
-
Optinose Announces Proposed Public Offering of Common Stock
15 Nov 2021 17:40:53 By Nasdaq GlobeNewswire
-
Optinose Reports Third Quarter 2021 Financial Results and Recent Operational Highlights
15 Nov 2021 16:26:45 By Nasdaq GlobeNewswire
-
Optinose Announces Reporting Date for Third Quarter 2021 Financial Results
10 Nov 2021 17:50:01 By Nasdaq GlobeNewswire
-
Optinose Completes Patient Recruitment in Second Pivotal Trial for XHANCE in Chronic Sinusitis
28 Oct 2021 06:59:00 By Nasdaq GlobeNewswire
-
Optinose to Present at the Cantor Virtual Global Healthcare Conference
22 Sep 2021 16:15:00 By Nasdaq GlobeNewswire
-
Optinose Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
25 Aug 2021 17:00:00 By Nasdaq GlobeNewswire
-
Optinose Reports Second Quarter 2021 Financial Results and Recent Operational Highlights
11 Aug 2021 07:00:01 By Nasdaq GlobeNewswire
-
Optinose Completes Patient Recruitment in Pivotal Trial for XHANCE in Chronic Sinusitis
30 Jul 2021 08:00:01 By Nasdaq GlobeNewswire